We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Medicines Agency’s (EMA) human medicines committee endorsed five new medicines — including a COVID-19 treatment and a gene therapy — during its monthly meeting held from March 21 to 24. Read More
The FDA has approved the first generic version of AstraZeneca’s Symbicort, a blockbuster drug-device combination product for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Read More
The FDA is asking its vaccines advisory committee to meet next month to make a recommendation on Pfizer’s and BioNTech’s March 15 request to amend its Emergency Use Authorization (EUA) for approval of a fourth shot/second booster of its COVID-19 vaccine Comirnaty for people age 65 and older. Read More